Prominent medical experts who have been involved in corporate marketing campaigns do not always disclose this involvement when publishing in medical and scientific journals, sitting on committees or taking-up education appointments. Rueben Hale reports.
Medical profession
Time to take on Australia’s toughest closed shop: specialist medicine
As long as there is a gross under-supply of specialists and an unwillingness to think about big changes to the way governments reimburse doctors services, the public will remain the big losers, writes Professor Ian Hickie.
Are drug companies hijacking consumer advocacy?
When an industry-funded so-called consumer advocate is a keynote speaker at such a conference, it shows how effectively pharmaceutical companies are hijacking consumer advocacy, writes Melissa Raven.
GP survey reveals heavy reliance on drug reps
More than 70 per cent of Australian general practitioners regularly see drug company sales representatives, writes Ray Moynihan.
Doctors and terror: an established pathology
With every doctor in the west named Patel or Habib now facing the prospect that their patients will be staring carefully at their white coats, checking for the outlines of a bomb-jacket, much bewilderment has been expressed at the juxtaposition of the healing profession and the delivery of death.
